Page last updated: 2024-09-04

withanolide d and diclofenac

withanolide d has been researched along with diclofenac in 1 studies

Compound Research Comparison

Studies
(withanolide d)
Trials
(withanolide d)
Recent Studies (post-2010)
(withanolide d)
Studies
(diclofenac)
Trials
(diclofenac)
Recent Studies (post-2010) (diclofenac)
250118,8741,8743,616

Protein Interaction Comparison

ProteinTaxonomywithanolide d (IC50)diclofenac (IC50)
Aldo-keto reductase family 1 member B10Homo sapiens (human)1.9
Prostaglandin G/H synthase 1 Bos taurus (cattle)0.003
Prostaglandin G/H synthase 1Ovis aries (sheep)1.3376
Interleukin-8Homo sapiens (human)0.008
Prostaglandin G/H synthase 1Homo sapiens (human)0.0415
Sodium- and chloride-dependent GABA transporter 1Rattus norvegicus (Norway rat)0.5
C-X-C chemokine receptor type 1Homo sapiens (human)0.012
Sodium- and chloride-dependent GABA transporter 2Rattus norvegicus (Norway rat)0.5
Sodium- and chloride-dependent GABA transporter 3Rattus norvegicus (Norway rat)0.5
Prostaglandin G/H synthase 2Homo sapiens (human)0.4165
Prostaglandin G/H synthase 2 Rattus norvegicus (Norway rat)0.5
Sodium- and chloride-dependent betaine transporterRattus norvegicus (Norway rat)0.5
Prostaglandin G/H synthase 2Ovis aries (sheep)1.6867
Prostaglandin G/H synthase 2Mus musculus (house mouse)0.0502
Solute carrier family 22 member 6Homo sapiens (human)4
Prostaglandin G/H synthase 1 Rattus norvegicus (Norway rat)0.5
P2Y purinoceptor 12Rattus norvegicus (Norway rat)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avasarala, H; Dinakaran, SK; Ghosh, S; Kanthasamy, N; Karanam, SR; Macharala, SP; Prabhakaran, Y1

Other Studies

1 other study(ies) available for withanolide d and diclofenac

ArticleYear
Molecular docking studies of withanolides against Cox-2 enzyme.
    Pakistan journal of pharmaceutical sciences, 2012, Volume: 25, Issue:3

    Topics: Binding Sites; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Models, Molecular; Protein Interaction Domains and Motifs; Withanolides

2012